Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine in Japanese PTSD patients
NCT00839397Phase 3Completed
- Sponsor
- GSK
- Start
- May 2002
- Primary completion
- Nov 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of paroxetine in post-traumatic stress disorder (PTSD), sponsored by GSK. Started May 2002; status: completed.
02
Drugs
paroxetine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00839397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00839397.